A detailed history of Mitchell Sinkler & Starr transactions in Cabot Corp stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 60,180 shares of CBT stock, worth $7.02 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
60,180
Previous 60,180 -0.0%
Holding current value
$7.02 Million
Previous $5.55 Million 0.34%
% of portfolio
1.43%
Previous 1.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.05 - $77.11 $285,616 - $354,937
-4,603 Reduced 7.11%
60,180 $4.02 Million
Q4 2021

Feb 01, 2022

BUY
$50.96 - $59.68 $3.3 Million - $3.87 Million
64,783 New
64,783 $3.64 Million

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $6.56B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.